Andy received his Ph.D. in Chemistry and B.Sc. in Chemistry and Biochemistry from the University of Toronto. Andrew has more than 25 years’ industrial experience in large and small R&D organizations. For the decade prior to joining MaRS Innovation, he was Vice President of Bodycote – a contract-research, development and testing organization with over 4,000 staff worldwide. He has managed contract medical-device development programs in areas including drug eluting stents, orthopeadic implants, drug-delivery technologies, wound dressings and custom synthesis for medical applications. For several years in the 1990s he ran a division at Ortech that provided technology consulting to investors and financial institutions on technology-based businesses.